Felix Pfister
Overview
Explore the profile of Felix Pfister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Modl L, Carnell L, Stein R, Kerpes A, Pfister F, Wirthl B, et al.
Front Bioeng Biotechnol
. 2025 Jan;
12():1498120.
PMID: 39845377
Background: With the help of superparamagnetic iron oxide nanoparticles (SPIONs), cells can be magnetically directed so that they can be accumulated at target sites. This principle can be used to...
2.
Pfister F, Carnell L, Loffler L, Boosz P, Schaft N, Dorrie J, et al.
MedComm (2020)
. 2025 Jan;
6(1):e70039.
PMID: 39764559
Therapies against hematological malignancies using chimeric antigen receptors (CAR)-T cells have shown great potential; however, therapeutic success in solid tumors has been constrained due to limited tumor trafficking and infiltration,...
3.
Singh J, Zlatar L, Munoz-Becerra M, Lochnit G, Herrmann I, Pfister F, et al.
Cell Commun Signal
. 2024 Sep;
22(1):435.
PMID: 39252008
The inducers of neutrophil extracellular trap (NET) formation are heterogeneous and consequently, there is no specific pathway or signature molecule indispensable for NET formation. But certain events such as histone...
4.
Adler M, Issoual I, Ruckert M, Deloch L, Meier C, Tschernig T, et al.
J Hazard Mater
. 2024 Apr;
471():134253.
PMID: 38642497
Micro- and nanoplastics (MNPs) are ubiquitous in the environment, resulting in the uptake of MNPs by a variety of organisms, including humans, leading to particle-cell interaction. Human macrophages derived from...
5.
Pfister F, Mehdorn M, Schwartner C, Seehofer D, Tautenhahn H, Struck M, et al.
Abdom Radiol (NY)
. 2024 Mar;
49(5):1376-1384.
PMID: 38528270
Purpose: Contrast enhancement of the adrenal gland defined by computed tomography (CT) was previously analyzed as a prognostic factor for critically ill patients in various diseases. However, no study investigated...
6.
Damm D, Suleiman E, Wagner J, Klessing S, Pfister F, Elsayed H, et al.
Eur J Pharm Biopharm
. 2023 Oct;
192:112-125.
PMID: 37797679
The encapsulation of HIV-unrelated T helper peptides into liposomal vaccines presenting trimers of the HIV-1 envelope glycoprotein (Env) on the surface (T helper liposomes) may recruit heterologous T cells to...
7.
Pfister F, Dorrie J, Schaft N, Buchele V, Unterweger H, Carnell L, et al.
Front Immunol
. 2023 Sep;
14:1223695.
PMID: 37662937
Background: Immunotherapy of cancer is an emerging field with the potential to improve long-term survival. Thus far, adoptive transfer of tumor-specific T cells represents an effective treatment option for tumors...
8.
Pfister F, Alexiou C, Janko C
Methods Mol Biol
. 2023 May;
2644:331-346.
PMID: 37142932
Immune cell therapies, such as adoptive T cell therapies, are an innovative and powerful treatment option for previously non-treatable diseases. Although immune cell therapies are thought to be very specific,...
9.
Behr J, Carnell L, Stein R, Pfister F, Friedrich B, Huber C, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497463
Superparamagnetic iron oxide nanoparticles (SPIONs) are used in nanomedicine as transporter systems for therapeutic cargos, or to magnetize cells to make them magnetically guidable. In cancer treatment, the site-directed delivery...
10.
Stein R, Pfister F, Friedrich B, Blersch P, Unterweger H, Arkhypov A, et al.
Molecules
. 2022 Nov;
27(21).
PMID: 36364241
Nanoformulations for delivering nucleotides into cells as vaccinations as well as treatment of various diseases have recently gained great attention. Applying such formulations for a local treatment strategy, e.g., for...